Biotechnology company and global drug delivery platform
innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently
announced the successful completion of its master collaborative research
agreement with the National Research Council of Canada (“NRC”) focused on
technical aspects of DehydraTECH(TM)’s drug-delivery processes (http://ibn.fm/R94q9). An article
further discussing the company reads, “Lexaria also noted that the National
Research Council of Canada study discovered the remarkable stability of
DehydraTECH technology, even under highly acidic conditions. ‘Other formulation
technologies by third parties that have not been tested for pH stability cannot
be relied upon to deliver stable quantities of the API in question within an
acidic beverage,’ the news release states. ‘Since mildly acidic formulas are
used in the vast majority of beverages sold in North America today, pH
stability testing is a necessary aspect of safely delivering cannabinoids
within popular beverage formats, and Lexaria’s technology is now proven capable
of doing so.’”
To view the full article, visit http://ibn.fm/mtzzU
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and higher effectiveness of lipophilic active molecules. Lexaria
has multiple patents pending in over 40 countries around the world and has
patents granted in the United States and in Australia for utilization of its
DehydraTECH delivery technology. Lexaria’s technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. For more information, visit the
company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
